Mixed Glioma: Clinical Trials

2 trials for Mixed Glioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2

Follow Mixed Glioma: new trials by email Literature Review of Mixed Glioma trials Research Report on Mixed Glioma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
MRI-guided laser ablation, Doxorubicin, Etoposide - Glioma, Pilocytic Astrocytoma
Phase 2TerminatedWashington University School of Medicine62015-08-142024-11-01
Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
ritonavir, lopinavir - Brain Tumor, Anaplastic Astrocytoma
Phase 2TerminatedCase Comprehensive Cancer Center192009-01-012013-06-10

Narrower conditions

Astrocytoma (2)  ·  Glioblastoma (2)  ·  Glioma (2)  ·  Oligodendroglioma (2)  ·  Brain Neoplasms (1)  ·  Ependymoma (1)  ·  Gliosarcoma (1)  ·  Optic Nerve Glioma (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neoplasms, Neuroepithelial (2)  ·  Nervous System Diseases (2)  ·  Nervous System Neoplasms (2)  ·  Neuroectodermal Tumors (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Cranial Nerve Diseases (1)  ·  Cranial Nerve Neoplasms (1)

Interventions

Doxorubicin (1)  ·  Dynamic Contrast Enhanced Magnetic Resonance Imaging (1)  ·  Etoposide (1)  ·  Lopinavir (1)  ·  Perfusion Magnetic Resonance Imaging (1)  ·  Ritonavir (1)  ·  etoposide phosphate (1)

Sponsors

Case Comprehensive Cancer Center (1)  ·  Washington University School of Medicine (1)

Countries

United States (2)

Top investigators

Andrew Cluster, M.D. (1)  ·  David Peereboom, MD (1)